UB Paderborn / Katalog / Suche / in CDI

Mapping of Murine Th1 Helper T-Cell Epitopes of Mycolyl Transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis

Infection and Immunity, 2003-01, Vol.71 (1), p.483-493

2003

Volltextzugriff (PDF)

Improved Tuberculosis DNA Vaccines by Formulation in Cationic Lipids

Infection and Immunity, 2002-07, Vol.70 (7), p.3681-3688

2002

Volltextzugriff (PDF)

What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?

European urology, 2000-04, Vol.37 (4), p.470-477

2000

Volltextzugriff (PDF)

Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG

Infection and Immunity, 1994-02, Vol.62 (2), p.363-370

1994

Volltextzugriff (PDF)

Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv

Vaccine, 2006-04, Vol.24 (16), p.3353-3364

2006

Volltextzugriff (PDF)

Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette–Guérin (BCG) in patients with superficial bladder cancer

Clinical and experimental immunology, 1997-07, Vol.109 (1), p.157-165

1997

Volltextzugriff (PDF)

Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection

Infection and immunity, 1998-04, Vol.66 (4), p.1527-1533

1998

Volltextzugriff (PDF)

Cross‐Reactive Immune Responses Against Mycobacterium bovis BCG in Mice Infected with Non‐Tuberculous Mycobacteria Belonging to the MAIS‐Group

Scandinavian journal of immunology, 1997-07, Vol.46 (1), p.16-26

1997

Volltextzugriff (PDF)

What Is the Optimal Regimen for BCG Intravesical Therapy?

European urology, 2000, Vol.37 (4), p.470-477

2000

Volltextzugriff (PDF)

What are the immunologically active components of Bacille Calmette‐Guérin in therapy of superficial bladder cancer?

International journal of cancer, 2000-09, Vol.87 (6), p.844-852

2000

Volltextzugriff (PDF)

2.12 Gaze position, distance and postural stability in young and old subjects

Gait & posture, 2005-06, Vol.21, p.S8-S8

2005

Volltextzugriff (PDF)

H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin

Infection and Immunity, 1988-12, Vol.56 (12), p.3196-3200

1988

Volltextzugriff (PDF)

Six Adult Cases with a Pseudo-Vestibular Syndrome Related to Vergence Abnormalities

Neuro-ophthalmology (Amsterdam : Aeolus Press. 1980), 2008, Vol.32 (2), p.93-104

2008

Volltextzugriff (PDF)

Antibody repertoire against culture filtrate antigens in wild house mice infected with Mycobacterium bovis BCG

Clinical and experimental immunology, 1990-11, Vol.82 (2), p.369-372

1990

Volltextzugriff (PDF)

Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder Cancer

The Journal of urology, 1997-02, Vol.157 (2), p.492-498

1997

Volltextzugriff (PDF)

SUPERFICIAL BLADDER TUMORS AND INCREASED REACTIVITY AGAINST MYCOBACTERIAL ANTIGENS BEFORE BACILLUS CALMETTE-GUERIN THERAPY

The Journal of urology, 1998-06, Vol.159 (6), p.1885-1891

1998

Volltextzugriff (PDF)

Le troisième et dernier cimetière de l'hôpital Saint-Jean de Bruxelles (1704-1784). Etude paléopathologique des ossements du cimetière Saint-Jean

Annales de la Societe belge d'histoire des hopitaux, 1982, Vol.20, p.2

1982

Volltextzugriff (PDF)

Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4 super(+) and CD8 super(+) T-cell epitopic repertoire broader than that stimulated by Mycobacteriurn tuberculosis H37Rv infection

Infection and immunity, 1998-04, Vol.66 (4), p.1527-1533

1998

Volltextzugriff (PDF)

Superficial bladder tumors and increased reactivity against mycobacterial antigens before Bacillus Calmette-Guerin therapy. Commentary

The Journal of urology, 1998, Vol.159 (6), p.1885-1891

1998

Volltextzugriff (PDF)

Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer. Commentary

The Journal of urology, 1997, Vol.157 (2), p.492-498

1997

Volltextzugriff (PDF)

Six Adult Cases with a Pseudo-Vestibular Syndrome Related to Vergence Abnormalities

Neuro-Ophthalmology, 2008, Vol.32 (2), p.93-104

2008

Volltextzugriff (PDF)

Can Primitive Farming Be Modernised?

Geographical Review, 1971, Vol.61 (1), p.158-159

Crist, Raymond E.

1971

Volltextzugriff (PDF)

The need of prolonged BCG treatment in superficial bladder cancer is suggested by the development of a peripheral immune response induced by BCG

Acta urologica Belgica, 1997-03, Vol.65 (1), p.1

1997

Volltextzugriff (PDF)

In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination

npj vaccines, 2021-06, Vol.6 (1), p.81-81, Article 81

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Mapping of Murine Th1 Helper T-Cell Epitopes of Mycolyl Transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis

Improved Tuberculosis DNA Vaccines by Formulation in Cationic Lipids

What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?

Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG

Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv

Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette–Guérin (BCG) in patients with superficial bladder cancer

Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection

Cross‐Reactive Immune Responses Against Mycobacterium bovis BCG in Mice Infected with Non‐Tuberculous Mycobacteria Belonging to the MAIS‐Group

What Is the Optimal Regimen for BCG Intravesical Therapy?

What are the immunologically active components of Bacille Calmette‐Guérin in therapy of superficial bladder cancer?

2.12 Gaze position, distance and postural stability in young and old subjects

H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin

Six Adult Cases with a Pseudo-Vestibular Syndrome Related to Vergence Abnormalities

Antibody repertoire against culture filtrate antigens in wild house mice infected with Mycobacterium bovis BCG

Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder Cancer

SUPERFICIAL BLADDER TUMORS AND INCREASED REACTIVITY AGAINST MYCOBACTERIAL ANTIGENS BEFORE BACILLUS CALMETTE-GUERIN THERAPY

Le troisième et dernier cimetière de l'hôpital Saint-Jean de Bruxelles (1704-1784). Etude paléopathologique des ossements du cimetière Saint-Jean

Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4 super(+) and CD8 super(+) T-cell epitopic repertoire broader than that stimulated by Mycobacteriurn tuberculosis H37Rv infection

Superficial bladder tumors and increased reactivity against mycobacterial antigens before Bacillus Calmette-Guerin therapy. Commentary

Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer. Commentary

Six Adult Cases with a Pseudo-Vestibular Syndrome Related to Vergence Abnormalities

Can Primitive Farming Be Modernised?

The need of prolonged BCG treatment in superficial bladder cancer is suggested by the development of a peripheral immune response induced by BCG

In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination

Suchergebnisse filtern